Развитие на фармацевтичната индустрия в българската икономика по време на COVID-19
Development of the Pharmaceutical Industry in the Bulgarian Economy During COVID-19

Author(s): Nadezhda Ilieva
Subject(s): Social Sciences, Economy, National Economy, Business Economy / Management, Sociology, Evaluation research, Health and medicine and law, Economic development
Published by: Университет за национално и световно стопанство (УНСС)
Keywords: pharmaceutical industry; bulgarian economy; COVID-19; resilience; SWOT analysis; Eurozone; regulatory framework; economic contribution; employment; industrial trends
Summary/Abstract: The pharmaceutical industry is one of the key sectors of the Bulgarian economy, playing an important role in public health, employment, and economic growth. This report examines the development of the industry in recent years, with a particular focus on the impact of the COVID-19 pandemic. The sector managed to maintain the production and supply of essential medicines while simultaneously adapting to increased demand for hospital pharmaceuticals and vaccines. The development of the industry is characterized by sustained growth in sales, expansion of generic medicines, and increased exports to the European Union. The Bulgarian pharmaceutical industry is distinguished by a well-structured regulatory system, including the Bulgarian Drug Agency and the National Health Insurance Fund, which ensure the quality, safety, and accessibility of pharmaceutical products. The sector occupies a significant position in the economy, contributing to national GDP and employment by providing jobs for thousands of specialists. The SWOT analysis identifies strengths such as a highly qualified workforce and a stable distribution network, weaknesses such as dependence on imported raw materials, opportunities in the fields of biotechnology and digital health, as well as threats arising from global supply chains and regulatory changes. Preparation for Bulgaria’s accession to the Eurozone will create new economic challenges and opportunities for the sector, including expected adjustments in pricing, cost optimization, and enhanced competitiveness. The Bulgarian pharmaceutical industry remains an important driver of the healthcare system and the economy, continuing to develop and adapt to contemporary requirements and global trends.

• Details
• Contents